Skip to content

Public FDA record

Z-0194-2020: Posey Connected Twice-As-Tough Cuffs

Recall record Z-0194-2020 for TIDI PRODUCTS. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0194-2020
Company in FDA record
TIDI PRODUCTS
FDA record creation date
Oct 25, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Not meeting design specifications.

Source facts

Action
On April 5th the firm sent letters to their customers stating the following: Next Steps: 1. Ensure that all caregivers and users of the Posey Connected Twice-As-Tough (TAT) Cuffs (nos. 2796 and 2797) are made aware of this Recall Notice. 2. Refer to the enclosed TAT Cuff Lot Number List (Attachment 1) and check your inventory to determine if your facility has any affected units. 3. Destroy affected TAT Cuff(s) by following the enclosed TAT Cuff Destruction Instructions (Attachment 2). Dispose of damaged products per your facilitys policy for BIOHAZARDOUS material. 4. Complete the enclosed Customer Response and Proof of Destruction Form and return this form to the TIDI Products Regulatory Department. 5. Product Replacement Product shipment will resume on or around April 12, 2019. Replacement orders will be fulfilled as Customer Response and Proof of Destruction Forms are received. Note: If you have zero inventory of affected product, please enter 0 in the Quantity section and return form as required. Distribution of this Recall Notice: Please distribute this Recall Notice to appropriate individuals within your organization and to any organization where the potentially affected devices were transferred or sold. Please maintain awareness of this notice and resulting action for a minimum of two years to ensure effectiveness of this corrective action. In cases where customers opt not to proceed with completion of the recall requirements described above, TIDI Products cannot accept any responsibility for safety related issues or legal liabilities caused by the failure to respond to this Recall Notice. We regret any inconvenience that this Recall Notice may cause. Note: Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Additional Comment If you have any further questions or require assistance completing the Cust
Initiated
2019-04-12
Root cause
Process control
Terminated
2020-07-22
Distribution
AK, AR, CA, CT, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MN, MO, MS, MT, NC, NH, NJ, NM, NY, PA, SC, TN, TX, UT, VA, VT, WI, and WV CANADA, FRANCE, and THE NETHERLANDS
Recall number
Z-0194-2020
Recall status
Terminated
CDRH record ID
171784
FDA record created
2019-10-25
Recall event number
82534

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗